Skip to content

Aldosterone Radioimmunoassay Test Kit

by Serono Laboratories, Inc. 510(k)

Active United States

510(k) K834428

Overview

This device is a radioimmunoassay test kit for aldosterone, classified under FDA product code CJM and regulatory category 21 CFR 862.1045. It is an in-vitro diagnostic tool designed to quantitatively measure aldosterone levels in serum and urine samples, aiding in clinical chemistry assessments. Aldosterone assays are critical for diagnosing and monitoring conditions such as primary aldosteronism, hypertension, and adrenal disorders. The test kit employs radioimmunoassay technology to detect and quantify hormone concentrations with precision.

The Aldosterone Radioimmunoassay Test Kit is supplied as a single-use diagnostic reagent system, intended for use in clinical laboratory settings by trained personnel. It requires no special storage conditions beyond those specified in the accompanying instructions, though handling radioactive materials necessitates adherence to radiation safety protocols. The kit received FDA 510(k) clearance (K834428) under the Traditional 510(k) Review pathway, determined to be Substantially Equivalent to a predicate device. No additional regulatory markings (e.g., CE marking) are indicated in the available data.

AI-generated from registry data, 1 Oct 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK834428 Date2 Mar 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CJM
Device Class
Class II
Regulation
21 CFR Part 862.1045
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Serono Laboratories, Inc.

See all devices from Serono Laboratories, Inc. →

Questions

  • What clinical conditions is this test kit designed to help diagnose or monitor?

    This Aldosterone Radioimmunoassay Test Kit is specifically developed to quantitatively measure aldosterone levels in serum and urine samples. It aids in diagnosing and monitoring conditions such as primary aldosteronism, hypertension, and adrenal disorders, where aldosterone levels play a key role in clinical assessment.

  • Is this test kit intended for single-use or reusable applications?

    The Aldosterone Radioimmunoassay Test Kit is supplied as a single-use diagnostic reagent system. This design ensures precision and safety, particularly given the handling of radioactive materials, which necessitates adherence to strict radiation safety protocols per the manufacturer’s instructions.

  • What type of samples can be tested with this kit, and how is it used?

    This kit is designed for in-vitro diagnostic use in clinical laboratory settings by trained personnel. It quantitatively measures aldosterone concentrations in both serum and urine samples, providing critical data for clinical chemistry assessments.

  • Are there any special storage requirements for this test kit beyond standard laboratory conditions?

    The kit does not require special storage conditions beyond those outlined in the accompanying instructions. However, because it involves radioactive materials, strict adherence to radiation safety protocols is mandatory during handling and storage to ensure user and environmental safety.

  • What regulatory pathway was followed for FDA clearance of this device?

    The Aldosterone Radioimmunoassay Test Kit received FDA 510(k) clearance under the Traditional 510(k) Review pathway, determined to be Substantially Equivalent (SESE) to a predicate device. The clearance number is K834428, and it falls under FDA product code CJM and regulatory category 21 CFR 862.1045.